Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001826466-25-000058
Filing Date
2025-05-13
Accepted
2025-05-13 14:50:10
Documents
44
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm   iXBRL 10-Q 301264
2 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 7148
3 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 3229
  Complete submission text file 0001826466-25-000058.txt   2003446

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE nika-20250513.xsd EX-101.SCH 17398
5 XBRL CALCULATION FILE nika-20250513_cal.xml EX-101.CAL 24770
6 XBRL DEFINITION FILE nika-20250513_def.xml EX-101.DEF 69951
7 XBRL LABEL FILE nika-20250513_lab.xml EX-101.LAB 149341
8 XBRL PRESENTATION FILE nika-20250513_pre.xml EX-101.PRE 133266
47 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 163315
Mailing Address 2269 MERRIMACK VALLEY AVENUE HENDERSON NV 89044
Business Address 2269 MERRIMACK VALLEY AVENUE HENDERSON NV 89044 7023263615
NIKA PHARMACEUTICALS, INC (Filer) CIK: 0001145604 (see all company filings)

EIN.: 900292940 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56234 | Film No.: 25939251
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)